WebSep 3, 2024 · Background: HASPIN, a mitotic kinase for Histone H3, is a promising target for anti-cancer therapy. However, as HASPIN is an atypical kinase with low similarity to … WebAug 30, 2024 · Haspin is required for chromosomal stability; hence, treatment with the haspin inhibitor CHR-6494 has been identified to induce apoptosis in cancer cells by inducing genomic instability (Quadri et al., 2024). Our data suggest that prolonged nuclear accumulation of fascin in response to haspin inhibition may also contribute to these …
Nuclear fascin regulates cancer cell survival eLife
WebOct 10, 2012 · Here, we further investigated the role of Haspin in the regulation of the CPC by means of a small-molecule ATP-competitive Haspin inhibitor, 5-iodotubercidin (5-Iodo-7-β-d-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, abbreviated as 5-ITu). 5-ITu was originally characterized as an inhibitor of adenosine kinase (Wotring and Townsend, … WebDec 1, 2024 · Haspin is a promising target for the design of inhibitors as potent anticancer drugs for cancer therapy [10], [11]. CHR6494 (3-(1H-indazol-5-yl)-N-propylimidazo[1,2-b]pyridazin-6-amine) is a novel Haspin inhibitor that targets the component of the mitotic machinery other than the microtubule [12]. CHR6494 inhibited cell proliferation and ... naismith award vs wooden award
Haspin: a promising target for the design of inhibitors as potent ...
WebApr 15, 2024 · Only a few preclinical studies of monovalent Haspin kinase inhibitors have been reported by 2024. For instance, CHR-6494 (62) (Table 3), containing an indazolyl-imidazo [1,2-b]pyridazine scaffold, exhibited high inhibitory potency toward Haspin (IC 50 = 2 nM) and showed a broad spectrum of anticancer effects. WebLDN-192960 is an inhibitor of Haspin and Dual-specificity Tyrosine-regulated Kinase 2 (DYRK2) with IC50s of 10 nM and 48 nM, respectively. - Mechanism of Action & Protocol. From 11:00 pm to 12:00 pm EST ( 8:00 … WebJun 1, 2024 · Novel 7-azaindole derivatives were investigated as potential inhibitors of selected protein kinases. • The most potent inhibitor (8l) exhibits an IC 50 value of 14 nM for Haspin, • Two other active compounds (8g and 8h) are dual inhibitors of CDK9/CyclinT and Haspin. • These compounds have potential as starting points for design of potent ... medline hoyer lift weight scale